Following the dramatic late-night resignation of Peter Marks last Friday, Steele, a senior advisor to the division, takes the ...

Amid a dramatic reshaping of the federal healthcare apparatus, the FDA has named an acting leader of its Center for Biologics Evaluation and Research. | Amid a dramatic reshaping of the federal ...

The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for ...

The U.S. Food and Drug Administration said on Tuesday that it had named Scott Steele as acting director of its Center for Biologics Evaluation and Research, replacing Peter Marks. Marks, who played a ...

The FDA saw a significant reduction in force Tuesday, and former FDA Commissioner Robert Califf said the industry is going to ...

Scott Steele, Ph.D., has been appointed as the acting director of the FDA's Center for Biologics Evaluation and Research. This significant move is expected to bring fresh perspectives to the ...

The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, ...

The Food and Drug Administration had already indicated that it approved the vaccine, but new agency leaders are now requesting more data. Meanwhile, FDA staffers who oversaw expert panel meetings on ...

Although HHS says it did not target FDA product reviewers or inspectors, FDA employees who assist with reviews in various capacities were let go, including project managers and staff in administration ...

(Reuters) -The U.S. Food and Drug Administration said on Tuesday that it had named Scott Steele as acting director of its Center for Biologics Evaluation and Research, replacing Peter Marks. Marks ...